Nanodelivery of cerebrolysin reduces pathophysiology of Parkinson's disease.
Ozkizilcik A, Sharma A, Lafuente JV, Muresanu DF, Castellani RJ, Nozari A, Tian ZR, Mössler H, Sharma HS.
Ozkizilcik A, et al. Among authors: castellani rj.
Prog Brain Res. 2019;245:201-246. doi: 10.1016/bs.pbr.2019.03.014. Epub 2019 Apr 2.
Prog Brain Res. 2019.
PMID: 30961868
Review.